Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia
Uy,G.L., Aldoss,I., Foster,M.C., Sayre,P.H., Wieduwilt,M.J., Advani,A.S., Godwin,J.E., Arellano,M.L., Sweet,K., Emadi,A., Ravandi,F., Erba,H.P., Byrne,M., Michaelis,L.C., Topp,M.S., Vey,N., Ciceri,F., Carrabba,M.G., Paolini,S., Huls,G., Jongen-Lavrencic,M., Wermke,M., Chevallier,P., Gyan,E., Recher,C., Stiff,P., Pettit,K., Lowenberg,B., Church,S., Anderson,E.K., Vadakekolathu,J., Santaguida,M.T., Rettig,M.P., Muth,J., Curtis,T., Fehr,E., Guo,K., Zhao,J., Bakkacha,O., Jacobs,K., Tran,K., Kaminker,P., Kostova,M., Bonvini,E., Walter,R.B., Davidson-Moncada,J.K., Rutella,S., Dipersio,J.F.
Revue : Blood -
2021
Volume : 137
Pages : 751-762